Nexscope

Analyze Historical Pricing to Detect Long-Term Market Decline

4 views 3 triesMay 27, 20260
Price History AnalyzerPricing Aanlysis
User
Analyze the price history of the "face wash" market and check whether there is a long-term price decline.
Assistant

I'll invoke the price history analyzer skill to examine the "face wash" market for long-term pricing trends.

Assistant
Assistant

Face Wash Market β€” Price History Analysis

Key Finding: Yes, there IS a long-term price decline (CRASHED trend)

The data confirms a significant downward pricing trend of -16.8% over the 90-day analysis period, classified as CRASHED by the analyzer.


Summary Metrics

MetricValueAssessment
Price War Score68/100🟠 HIGH β€” Active price war
Price Trend-16.8%CRASHED
Volatility (PVI)11.2%HIGH
Current Avg Price$10.97Down from ~$13.20
Price Range$5.18 – $19.99Wide spread
Price Drops (90d)11 eventsFrequent discounting
Buy Box StabilityVery StableSingle dominant sellers

Price War Score Breakdown

FactorScoreMax
Volatility1735
Downward Trend2525 (maxed out)
Price Drops Frequency2525 (maxed out)
Buy Box Instability215
Total68100

The trend and price-drop factors are both at maximum β€” this confirms sustained, structural price erosion, not just temporary promotions.


Notable Recent Price Events

DateProductChange
Mar 25, 2026Neutrogena Hydro Boost$9.99 β†’ $6.63 (-33.6%)
Apr 1, 2026Neutrogena Hydro Boost$6.63 β†’ $9.99 (+50.7%)

Flash drops like -33% followed by rebounds suggest aggressive promotional warfare between sellers.


Top Products Analyzed

ProductPriceReviewsBSR Trend
Neutrogena Ultra Gentle$10.9716.9KIMPROVING
Aveeno Positively Radiant$8.1238.7Kβ€”
Beauty of Joseon Cleanser$13.005.9KIMPROVING
Neutrogena Hydro Boost$9.995.0KSTABLE
La Roche-Posay Toleriane$19.9948.8KSTABLE

Conclusions & Recommendations

  1. Long-term decline confirmed β€” The -16.8% trend over 90 days with 11 price drops is structural, not seasonal. Margins are compressing across the category.

  2. Active price war β€” Score 68 (HIGH) means sellers are aggressively undercutting each other, especially in the $8–$12 segment.

  3. Premium brands holding β€” La Roche-Posay ($19.99) and CeraVe ($15.97) maintain stable pricing. The war is concentrated in the mid-tier.

  4. Entry advice:

    • πŸ”΄ Avoid competing on price in the $8–$12 range
    • πŸ’‘ Differentiate through bundling, premium positioning, or niche formulations (e.g., Korean beauty at $13+ appears resilient)
    • Factor continued price erosion of ~5-8% per quarter into margin projections